Nutritional Management of Acute Kidney Injury

Nutritional Management of Renal Disease

Volumn , Issue , 2013, Pages 605-627

  Druml, Wilfred ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884026223     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-391934-2.00036-9     Document Type: Chapter

References (135)

1. Druml W. Acute renal failure is not a "cute" renal failure!. Intensive Care Med 2004, 30:1886-1890.
2. Kelly K.J. Acute renal failure: much more than a kidney disease. Semin Nephrol 2006, 26:105-113.
3. Om P., Hohenegger M. Energy metabolism in acute uremic rats. Nephron 1980, 25:249-253.
4. Soop M., Forsberg E., Thorne A., Alvestrand A. Energy expenditure in postoperative multiple organ failure with acute renal failure. Clin Nephrol 1989, 31:139-145.
5. Schneeweiss B., Graninger W., Stockenhuber F., et al. Energy metabolism in acute and chronic renal failure. Am J Clin Nutr 1990, 52:596-601.
6. Arabi Y.M., Tamim H.M., Dhar G.S., et al. Permissive underfeeding and intensive insulin therapy in critically ill patients: a randomized controlled trial. Am J Clin Nutr 2011, 93:569-577.
7. Dissanaike S., Shelton M., Warner K., O'Keefe G.E. The risk for bloodstream infections is associated with increased parenteral caloric intake in patients receiving parenteral nutrition. Crit Care 2007, 11:R114.
8. Fiaccadori E., Maggiore U., Rotelli C., et al. Effects of different energy intakes on nitrogen balance in patients with acute renal failure: a pilot study. Nephrol Dial Transplant 2005, 20:1976-1980.
9. Cano N., Fiaccadori E., Tesinsky P., et al. ESPEN Guidelines on Enteral Nutrition: Adult renal failure. Clin Nutr 2006, 25:295-310.
10. Flugel-Link R.M., Salusky I.B., Jones M.R., Kopple J.D. Protein and amino acid metabolism in posterior hemicorpus of acutely uremic rats. Am J Physiol 1983, 244:E615-E623.
11. Clark A.S., Mitch W.E. Muscle protein turnover and glucose uptake in acutely uremic rats. Effects of insulin and the duration of renal insufficiency. J Clin Invest 1983, 72:836-845.
12. Maroni B.J., Haesemeyer R.W., Kutner M.H., Mitch W.E. Kinetics of system A amino acid uptake by muscle: effects of insulin and acute uremia. Am J Physiol 1990, 258:F1304-F1310.
13. Druml W., Kelly R.A., May R.C., Mitch W.E. Abnormal cation transport in uremia. Mechanisms in adipocytes and skeletal muscle from uremic rats. J Clin Invest 1988, 81:1197-1203.
14. Druml W., Fischer M., Liebisch B., Lenz K., Roth E. Elimination of amino acids in renal failure. Am J Clin Nutr 1994, 60:418-423.
15. Druml W., Burger U., Kleinberger G., Lenz K., Laggner A. Elimination of amino acids in acute renal failure. Nephron 1986, 42:62-67.
16. Garibotto G, Sofia A, Saffioti S, Bonanni A, Mannucci I, Verzola D. Amino acid and protein metabolism in the human kidney and in patients with chronic kidney disease. Clin Nutr;29:424-433.
17. Nijveldt R.J., Siroen M.P., Teerlink T., van Leeuwen P.A. Elimination of asymmetric dimethylarginine by the kidney and the liver: a link to the development of multiple organ failure?. J Nutr 2004, 134:2848S-2852S. discussion 2853S.
18. Druml W., Roth E., Lenz K., Lochs H., Kopsa H. Phenylalanine and tyrosine metabolism in renal failure: dipeptides as tyrosine source. Kidney Int Suppl 1989, 27:S282-S286.
19. Druml W., Lochs H., Roth E., Hubl W., Balcke P., Lenz K. Utilization of tyrosine dipeptides and acetyltyrosine in normal and uremic humans. Am J Physiol 1991, 260:E280-E285.
20. Cianciaruso B., Bellizzi V., Napoli R., Sacca L., Kopple J.D. Hepatic uptake and release of glucose, lactate, and amino acids in acutely uremic dogs. Metabolism 1991, 40:261-269.
21. Hu Z., Wang H., Lee I.H., Du J., Mitch W.E. Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice. J Clin Invest 2009, 119:3059-3069.
22. Zager R.A., Johnson A.C., Hanson S.Y., Lund S. Ischemic proximal tubular injury primes mice to endotoxin-induced TNF-alpha generation and systemic release. Am J Physiol Renal Physiol 2005, 289:F289-F297.
23. Lecker S.H., Mitch W.E. Proteolysis by the ubiquitin-proteasome system and kidney disease. J Am Soc Nephrol 2011, 22:821-824.
24. Bailey J.L., Mitch W.E. Twice-told tales of metabolic acidosis, glucocorticoids, and protein wasting: what do results from rats tell us about patients with kidney disease?. Semin Dial 2000, 13:227-231.
25. Druml W. Metabolic aspects of continuous renal replacement therapies. Kidney Int Suppl 1999, S56-S61.
26. Simmons E.M., Himmelfarb J., Sezer M.T., et al. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 2004, 65:1357-1365.
27. Kierdorf H. Continuous versus intermittent treatment: clinical results in acute renal failure. Contrib Nephrol 1991, 93:1-12.
28. Chima C.S., Meyer L., Hummell A.C., et al. Protein catabolic rate in patients with acute renal failure on continuous arteriovenous hemofiltration and total parenteral nutrition. J Am Soc Nephrol 1993, 3:1516-1521.
29. Macias W.L., Alaka K.J., Murphy M.H., Miller M.E., Clark W.R., Mueller B.A. Impact of the nutritional regimen on protein catabolism and nitrogen balance in patients with acute renal failure. JPEN J Parenter Enteral Nutr 1996, 20:56-62.
30. Fiaccadori E., Cremaschi E., Regolisti G. Nutritional assessment and delivery in renal replacement therapy patients. Semin Dial 2011, 24:169-175.
31. Leblanc M., Garred L.J., Cardinal J., et al. Catabolism in critical illness: estimation from urea nitrogen appearance and creatinine production during continuous renal replacement therapy. Am J Kidney Dis 1998, 32:444-453.
32. Marshall M.R., Golper T.A., Shaver M.J., Alam M.G., Chatoth D.K. Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy. Am J Kidney Dis 2002, 39:556-570.
33. Ganesan M.V., Annigeri R.A., Shankar B., et al. The protein equivalent of nitrogen appearance in critically ill acute renal failure patients undergoing continuous renal replacement therapy. J Ren Nutr 2009, 19:161-166.
34. Hasik J., Hryniewiecki L., Baczyk K., Grala T. [Minimal protein requirements in patients with acute kidney failure]. Pol Arch Med Wewn 1979, 61:29-36.
35. Martindale R.G., McClave S.A., Vanek V.W., et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition: Executive Summary. Crit Care Med 2009, 37:1757-1761.
36. Singer P., Berger M.M., Van den Berghe G., et al. ESPEN Guidelines on Parenteral Nutrition: intensive care. Clin Nutr 2009, 28:387-400.
37. Bellomo R., Seacombe J., Daskalakis M., et al. A prospective comparative study of moderate versus high protein intake for critically ill patients with acute renal failure. Ren Fail 1997, 19:111-120.
38. Scheinkestel C.D., Adams F., Mahony L., et al. Impact of increasing parenteral protein loads on amino acid levels and balance in critically ill anuric patients on continuous renal replacement therapy. Nutrition 2003, 19:733-740.
39. Basi S., Pupim L.B., Simmons E.M., et al. Insulin resistance in critically ill patients with acute renal failure. Am J Physiol Renal Physiol 2005, 289:F259-F264.
40. May R.C., Clark A.S., Goheer M.A., Mitch W.E. Specific defects in insulin-mediated muscle metabolism in acute uremia. Kidney Int 1985, 28:490-497.
41. Weisinger J., Swenson R.S., Greene W., Taylor J.B., Reaven G.M. Comparison of the effects of metabolic acidosis and acute uremia on carbohydrate tolerance. Diabetes 1972, 21:1109-1115.
42. Cianciaruso B., Sacca L., Terracciano V., et al. Insulin metabolism in acute renal failure. Kidney Int Suppl 1987, 22:S109-S112.
43. Druml W., Laggner A., Widhalm K., Kleinberger G., Lenz K. Lipid metabolism in acute renal failure. Kidney Int Suppl 1983, 16:S139-S142.
44. Druml W., Fischer M., Sertl S., Schneeweiss B., Lenz K., Widhalm K. Fat elimination in acute renal failure: long-chain vs. medium-chain triglycerides. Am J Clin Nutr 1992, 55:468-472.
45. Druml W., Zechner R., Magometschnigg D., et al. Post-heparin lipolytic activity in acute renal failure. Clin Nephrol 1985, 23:289-293.
46. Schurr D., Levy E., Goldstein R., Stankiewicz H., Pomeranz A., Drukker A. Intestinal fat malabsorption in the uremic rat. Int J Pediatr Nephrol 1987, 8:129-134.
47. Druml W. Nutritional management of acute renal failure. J Ren Nutr 2005, 15:63-70.
48. Wanner C., Riegel W., Schaefer R.M., Horl W.H. Carnitine and carnitine esters in acute renal failure. Nephrol Dial Transplant 1989, 4:951-956.
49. Jones N.E., Heyland D.K. Pharmaconutrition: a new emerging paradigm. Curr Opin Gastroenterol 2008, 24:215-222.
50. Metnitz G.H., Fischer M., Bartens C., Steltzer H., Lang T., Druml W. Impact of acute renal failure on antioxidant status in multiple organ failure. Acta Anaesthesiol Scand 2000, 44:236-240.
51. Himmelfarb J., McMonagle E., Freedman S., et al. Oxidative stress is increased in critically ill patients with acute renal failure. J Am Soc Nephrol 2004, 15:2449-2456.
52. Berger M.M., Shenkin A., Revelly J.P., et al. Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients. Am J Clin Nutr 2004, 80:410-416.
53. Madl C., Kranz A., Liebisch B., Traindl O., Lenz K., Druml W. Lactic acidosis in thiamine deficiency. Clin Nutr 1993, 12:108-111.
54. Spargias K., Alexopoulos E., Kyrzopoulos S., et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004, 110:2837-2842.
55. Stepien K.M., Prinsloo P., Hitch T., McCulloch T.A., Sims R. Acute renal failure, microangiopathic haemolytic anemia, and secondary oxalosis in a young female patient. Int J Nephrol 2011, 2011:679160.
56. Canavese C., Petrarulo M., Massarenti P., et al. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients. Am J Kidney Dis 2005, 45:540-549.
57. Druml W., Schwarzenhofer M., Apsner R., Horl W.H. Fat-soluble vitamins in patients with acute renal failure. Miner Electrolyte Metab 1998, 24:220-226.
58. Lee P., Nair P., Eisman J.A., Center J.R. Vitamin D deficiency in the intensive care unit: an invisible accomplice to morbidity and mortality?. Intensive Care Med 2009, 35:2028-2032.
59. Amrein K., Sourij H., Wagner G., et al. Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study. Crit Care 2011, 15:R104.
60. Nathens A.B., Neff M.J., Jurkovich G.J., et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002, 236:814-822.
61. Gerlach T.H., Zile M.H. Upregulation of serum retinol in experimental acute renal failure. Faseb J 1990, 4:2511-2517.
62. Lipkin A.C., Lenssen P. Hypervitaminosis in pediatric hematopoietic stem cell patients requiring renal replacement therapy. Nutr Clin Pract 2008, 23:621-629.
63. Pasko D.A., Churchwell M.D., Btaiche I.F., Jain J.C., Mueller B.A. Continuous venovenous hemodiafiltration trace element clearance in pediatric patients: a case series. Pediatr Nephrol 2009, 24:807-813.
64. Koenig J.S., Fischer M., Bulant E., Tiran B., Elmadfa I., Druml W. Antioxidant status in patients on chronic hemodialysis therapy: impact of parenteral selenium supplementation. Wien Klin Wochenschr 1997, 109:13-19.
65. Angstwurm M.W., Engelmann L., Zimmermann T., et al. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 2007, 35:118-126.
66. Andrews P.J., Avenell A., Noble D.W., et al. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. Bmj 2011, 342:d1542.
67. Heyland D.K., Dhaliwal R., Suchner U., Berger M.M. Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 2005, 31:327-337.
68. Heyland D.K., Jones N., Cvijanovich N.Z., Wong H. Zinc supplementation in critically ill patients: a key pharmaconutrient?. JPEN J Parenter Enteral Nutr 2008, 32:509-519.
69. Santos M.S., Seguro A.C., Andrade L. Hypomagnesemia is a risk factor for nonrecovery of renal function and mortality in AIDS patients with acute kidney injury. Braz J Med Biol Res 2011, 43:316-323.
70. Seguro A.C., de Araujo M., Seguro F.S., Rienzo M., Magaldi A.J., Campos S.B. Effects of hypokalemia and hypomagnesemia on zidovudine (AZT) and didanosine (ddI) nephrotoxicity in rats. Clin Nephrol 2003, 59:267-272.
71. Markowitz G.S., Perazella M.A. Acute phosphate nephropathy. Kidney Int 2009, 76:1027-1034.
72. Haas M., Ohler L., Watzke H., Bohmig G., Prokesch R., Druml W. The spectrum of acute renal failure in tumour lysis syndrome. Nephrol Dial Transplant 1999, 14:776-779.
73. Demirjian S., Teo B.W., Guzman J.A., et al. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant 2011, 26:3508-3514.
74. Schiffl H., Lang S.M. Severe acute hypophosphatemia during renal replacement therapy adversely affects outcome of critically ill patients with acute kidney injury. Int Urol Nephrol 2012.
75. Gariballa S. Refeeding syndrome: a potentially fatal condition but remains underdiagnosed and undertreated. Nutrition 2008, 24:604-606.
76. Tan H.K., Bellomo R., M'Pisi D.A., Ronco C. Ionized serum calcium levels during acute renal failure: intermittent hemodialysis vs. Continuous hemodiafiltration. Ren Fail 2002, 24:19-27.
77. Hastbacka J., Pettila V. Prevalence and predictive value of ionized hypocalcemia among critically ill patients. Acta Anaesthesiol Scand 2003, 47:1264-1269.
78. Pietrek J., Kokot F., Kuska J. Serum 25-hydroxyvitamin D and parathyroid hormone in patients with acute renal failure. Kidney Int 1978, 13:178-185.
79. Graziani G, Calvetta A, Cucchiari D, Valaperta S, Montanelli A. Life-threatening hypercalcemia in patients with rhabdomyolysis-induced oliguric acute renal failure. J Nephrol;24:128-131.
80. Moyses-Neto M., Guimaraes F.M., Ayoub F.H., Vieira-Neto O.M., Costa J.A., Dantas M. Acute renal failure and hypercalcemia. Ren Fail 2006, 28:153-159.
81. Satish R., Gokulnath G. Serum magnesium in recovering acute renal failure. Indian J Nephrol 2008, 18:101-104.
82. Soliman H.M., Mercan D., Lobo S.S., Melot C., Vincent J.L. Development of ionized hypomagnesemia is associated with higher mortality rates. Crit Care Med 2003, 31:1082-1087.
83. de Araujo M., Andrade L., Coimbra T.M., Rodrigues A.C., Seguro A.C. Magnesium supplementation combined with N-acetylcysteine protects against postischemic acute renal failure. J Am Soc Nephrol 2005, 16:3339-3349.
84. Hamill-Ruth R.J., McGory R. Magnesium repletion and its effect on potassium homeostasis in critically ill adults: results of a double-blind, randomized, controlled trial. Crit Care Med 1996, 24:38-45.
85. Badalamenti S., Gines P., Arroyo V. Renal effects of amino acid administration in cirrhosis. Gastroenterology 1993, 104:1886.
86. Singer P. High-dose amino acid infusion preserves diuresis and improves nitrogen balance in non-oliguric acute renal failure. Wien Klin Wochenschr 2007, 119:218-222.
87. Kim Y.S., Jung M.H., Choi M.Y., et al. Glutamine attenuates tubular cell apoptosis in acute kidney injury via inhibition of the c-Jun N-terminal kinase phosphorylation of 14-3-3. Crit Care Med 2009, 37:2033-2044.
88. Schramm L., Seibold A., Schneider R., Zimmermann J., Netzer K.O., Wanner C. Ischemic acute renal failure in the rat: effects of L-arginine and superoxide dismutase on renal function. J Nephrol 2008, 21:229-235.
89. Miller H.I., Dascalu A., Rassin T.A., Wollman Y., Chernichowsky T., Iaina A. Effects of an acute dose of L-arginine during coronary angiography in patients with chronic renal failure: a randomized, parallel, double-blind clinical trial. Am J Nephrol 2003, 23:91-95.
90. Toback F.G. Regeneration after acute tubular necrosis. Kidney Int 1992, 41:226-246.
91. Abel R.M., Beck C.H., Abbott W.M., Ryan J.A., Barnett G.O., Fischer J.E. Improved survival from acute renal failure after treatment with intravenous essential L-amino acids and glucose. Results of a prospective, double-blind study. N Engl J Med 1973, 288:695-699.
92. Roberts P.R., Black K.W., Zaloga G.P. Enteral feeding improves outcome and protects against glycerol-induced acute renal failure in the rat. Am J Respir Crit Care Med 1997, 156:1265-1269.
93. Mouser J.F., Hak E.B., Kuhl D.A., Dickerson R.N., Gaber L.W., Hak L.J. Recovery from ischemic acute renal failure is improved with enteral compared with parenteral nutrition. Crit Care Med 1997, 25:1748-1754.
94. Saadeh E., Ikizler T.A., Shyr Y., Hakim R.M., Himmelfarb J. Recombinant human growth hormone in patients with acute renal failure. J Ren Nutr 2001, 11:212-219.
95. Takala J., Ruokonen E., Webster N.R., et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999, 341:785-792.
96. Hirschberg R., Kopple J., Lipsett P., et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 1999, 55:2423-2432.
97. Acker C.G., Singh A.R., Flick R.P., Bernardini J., Greenberg A., Johnson J.P. A trial of thyroxine in acute renal failure. Kidney Int 2000, 57:293-298.
98. Joannidis M., Druml W., Forni L.G., et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology. ESICM. Intensive Care Med 2010, 36:392-411.
99. Marenzi G., De Metrio M., Rubino M., et al. Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention. Am Heart J 2011, 160:1170-1177.
100. Schetz M., Vanhorebeek I., Wouters P.J., Wilmer A., Van den Berghe G. Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol 2008, 19:571-578.
101. Bitla A.R., Reddy P.E., Manohar S.M., Vishnubhotla S.V. Pemmaraju Venkata Lakshmi Narasimha SR. Effect of a single hemodialysis session on inflammatory markers. Hemodial Int 2011, 14:411-417.
102. Caglar K., Peng Y., Pupim L.B., et al. Inflammatory signals associated with hemodialysis. Kidney Int 2002, 62:1408-1416.
103. Berg A., Norberg A., Martling C.R., Gamrin L., Rooyackers O., Wernerman J. Glutamine kinetics during intravenous glutamine supplementation in ICU patients on continuous renal replacement therapy. Intensive Care Med 2007, 33:660-666.
104. Frankenfield D.C., Reynolds H.N. Nutritional effect of continuous hemodiafiltration. Nutrition 1995, 11:388-393.
105. Maxvold N.J., Smoyer W.E., Custer J.R., Bunchman T.E. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis. Crit Care Med 2000, 28:1161-1165.
106. Tang X.Y., Ren J.A., Gu G.S., Chen J., Fan Y.P., Li J.S. [Protein loss in critically ill patients during continuous veno-venous hemofiltration]. Zhonghua Wai Ke Za Zhi 2011, 48:830-833.
107. Morena M., Cristol J.P., Bosc J.Y., et al. Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant 2002, 17:422-427.
108. Meier-Kriesche H.U., Gitomer J., Finkel K., DuBose T. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001, 29:748-752.
109. Broman M., Carlsson O., Friberg H., Wieslander A., Godaly G. Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy. Acta Anaesthesiol Scand 2011, 55:39-45.
110. Fiaccadori E., Lombardi M., Leonardi S., Rotelli C.F., Tortorella G., Borghetti A. Prevalence and clinical outcome associated with preexisting malnutrition in acute renal failure: a prospective cohort study. J Am Soc Nephrol 1999, 10:581-593.
111. Druml W., Metnitz B., Schaden E., Bauer P., Metnitz P.G. Impact of body mass on incidence and prognosis of acute kidney injury requiring renal replacement therapy. Intensive Care Med 2010, 36:1221-1228.
112. Baliga R., George V.T., Ray P.E., Holliday M.A. Effects of reduced renal function and dietary protein on muscle protein synthesis. Kidney Int 1991, 39:831-835.
113. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012, 2:1-138.
114. Metnitz P.G., Krenn C.G., Steltzer H., et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002, 30:2051-2058.
115. Scheinkestel C.D., Kar L., Marshall K., et al. Prospective randomized trial to assess caloric and protein needs of critically ill, anuric, ventilated patients requiring continuous renal replacement therapy. Nutrition 2003, 19:909-916.
116. Druml W., Mitch W.E. Enteral nutrition in renal disease. Clinical Nutrition: Enteral and Tube Feeding 2005, 471-485. WB Saunders, Philadelphia. 4th ed. Rolandelli, Bankhead, Boullata, Campher (Eds.).
117. Silva A.P., Freire C.C., Gondim F.A., et al. Bilateral nephrectomy delays gastric emptying of a liquid meal in awake rats. Ren Fail 2002, 24:275-284.
118. Krishnamurthy V.M., Wei G., Baird B.C., et al. High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int 2011.
119. Holzinger U., Brunner R., Miehsler W., et al. Jejunal tube placement in critically ill patients: A prospective, randomized trial comparing the endoscopic technique with the electromagnetically visualized method. Crit Care Med 2011, 39:73-77.
120. Doig G.S., Heighes P.T., Simpson F., Sweetman E.A., Davies A.R. Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials. Intensive Care Med 2009, 35:2018-2027.
121. Fiaccadori E., Maggiore U., Giacosa R., et al. Enteral nutrition in patients with acute renal failure. Kidney Int 2004, 65:999-1008.
122. Casaer M.P., Mesotten D., Hermans G., et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med 2011, 365:506-517.
123. Smolle K.H., Kaufmann P., Holzer H., Druml W. Intradialytic parenteral nutrition in malnourished patients on chronic haemodialysis therapy. Nephrol Dial Transplant 1995, 10:1411-1416.
124. Smolle K.H., Kaufmann P., Fleck S., et al. Influence of a novel amino acid solution (enriched with the dipeptide glycyl-tyrosine) on plasma amino acid concentration of patients with acute renal failure. Clin Nutr 1997, 16:239-246.
125. Roth E, Druml W. Plasma amino acid imbalance: dangerous in chronic diseases? Curr Opin Clin Nutr Metab Care;14:67-74.
126. Griffiths R.D., Jones C., Palmer T.E. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 1997, 13:295-302.
127. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359-1367.
128. Mayer K., Seeger W. Fish oil in critical illness. Curr Opin Clin Nutr Metab Care 2008, 11:121-127.
129. Hassan I.R., Gronert K. Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1. J Immunol 2009, 182:3223-3232.
130. Turpin R.S., Canada T., Liu F.X., Mercaldi C.J., Pontes-Arruda A., Wischmeyer P. Nutrition therapy cost analysis in the US: pre-mixed multi-chamber bag vs. compounded parenteral nutrition. Appl Health Econ Health Policy 2011, 9:281-292.
131. Feinstein E.I., Blumenkrantz M.J., Healy M., et al. Clinical and metabolic responses to parenteral nutrition in acute renal failure. A controlled double-blind study. Medicine (Baltimore) 1981, 60:124-137.
132. Feinstein E.I., Kopple J.D., Silberman H., Massry S.G. Total parenteral nutrition with high or low nitrogen intakes in patients with acute renal failure. Kidney Int Suppl 1983, 16:S319-S323.
133. Pupim L.B., Flakoll P.J., Brouillette J.R., Levenhagen D.K., Hakim R.M., Ikizler T.A. Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J Clin Invest 2002, 110:483-492.
134. Parienti JJ, Dugue AE, Daurel C, et al. Continuous renal replacement therapy may increase the risk of catheter infection. Clin J Am Soc Nephrol 5:1489-1496.
135. Prowle JR, Echeverri JE, Ligabo EV, Ronco C, Bellomo R. Fluid balance and acute kidney injury. Nat Rev Nephrol 6:107-115.